Only about 10% of candidates for surgical intervention for movement disorders end up undergoing surgery. Our latest podcast discusses new approaches that may increase that percentage.
With scarce data on how these conditions affect each other, nimbleness may be the best tool neurologists can deploy when managing movement disorders in this time of pandemic.
As demand swells for movement disorder expertise, a special journal issue from the World Congress on Parkinson’s Disease and Related Disorders delivers an essential update for neurologists worldwide.
The new director of our DBS program looks ahead to emerging applications for DBS and advancements in related technology, from directional leads to closed-loop stimulation.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Tuesdays are Dr. Hubert Fernandez’s favorite day of the week, because that’s when he has 12 slots devoted to virtual visits. The neurologist explains how distance health is transforming the way he practices.
The International Association of Parkinsonism and Related Disorders has tapped this neurologist to edit its journal and chair the scientific program for its world congress. He shares his plans and distinctly global insights.
Outcomes from Cleveland Clinic’s use of chemodenervation therapy for movement disorders and migraine underscore why this modality is well worth a try before weighing more invasive therapies.